After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NASDAQ-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. The current market capitalization of Pacific Biosciences of California Inc is $1.14B. A total of 13.72 million shares were traded on the day, compared to an average of 8.61M shares.
In the most recent transaction, Meline David W bought 40,000 shares of PACB for 4.40 per share on Mar 06 ’24. After the transaction, the Director now owns 40,000 company shares. In a previous transaction on Mar 04 ’24, HENRY CHRISTIAN O sold 14,177 shares at 4.87 per share. PACB shares that the insider owns now total 2,596,670.
Among the insiders who sold shares, Van Oene Mark disposed of 9,186 shares on Mar 04 ’24 at a per-share price of $4.87. This resulted in the insider holding 1,668,826 shares of PACB after the transaction. In another insider transaction, Kim Susan G. sold 5,275 shares at $4.87 per share on Mar 04 ’24. Company shares held by the insider now total 712,260.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, PACB has a high of $14.55 and a low of $4.00.
As of this writing, PACB has an earnings estimate of -$0.27 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of -$0.23 per share and a lower estimate of -$0.3. The company reported an EPS of -$0.26 in the last quarter, which was 21.20% higher than expectations of -$0.33.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. PACB’s latest balance sheet shows that the firm has $1.04B in Cash & Short Term Investments as of fiscal 2021. There were $955.36M in debt and $71.71M in liabilities at the time. Its Book Value Per Share was $2.62, while its Total Shareholder’s Equity was $790.99M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PACB is Buy with a score of 4.29.
